NEW YORK (GenomeWeb) – Indi Molecular has developed a barcoding-based screening system that it said lowers the time required to generate one of its protein catalyzed capture agents from 75 to 80 days to around 15 days.

According to Albert Luderer, the company's cofounder and CEO, the system allows for "truly high-throughput PCC creation," enabling rapid creation of the PCC affinity agents, which Indi is positioning for use in therapeutic, imaging, and diagnostic applications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.